You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endosomal toll-like receptor 3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Testicular Torsion and TLR 4 Was Investigated Trial (Toll-like receptor 4)

Completed
  • Testicular Torsion and TLR 4 Was Investigated
  • Toll-like receptor 4
  • (no location specified)
Sep 23, 2022

Spondylitis, Tuberculosis Trial in Makassar (400 IU, 5000 IU, 10000 IU)

Not yet recruiting
  • Spondylitis
  • Tuberculosis
  • 400 IU
  • +3 more
  • Makassar, South Sulawesi, Indonesia
    Wahidin Sudirohusodo General Hospital
May 11, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam University Medical Centre (location VUmc)
Dec 18, 2022

Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 20, 2021

HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

Recruiting
  • HIV Infections
  • HIVIS DNA/MVA-CMDR
  • +2 more
  • Tygerberg Hills, Cape Town, South Africa
    Stellenbosch University
Apr 20, 2022

Hepatitis B Trial in Baltimore, Falls Church (Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B])

Withdrawn
  • Hepatitis B
  • Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]
  • Baltimore, Maryland
  • +1 more
Jul 19, 2022

Toll-like Receptors 3 , 7 and 9 in Peripheral Blood Mononuclear

Not yet recruiting
  • COVID-19 Respiratory Infection
  • blood sample
  • (no location specified)
Oct 21, 2021

Novel Mechanisms and Approaches to Treat Neonatal Sepsis

Recruiting
  • Complication of Prematurity
  • Immunologic Deficiency Syndromes
  • Adjuvant
  • Blood Collection
  • Gainesville, Florida
    UF Health
Nov 4, 2021

Asthma Trial in Nashville (Semaglutide Pen Injector 2.4mg weekly, Placebo)

Not yet recruiting
  • Asthma
  • Semaglutide Pen Injector 2.4mg weekly
  • Placebo
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Jun 22, 2022

Polycystic Ovary Syndrome Trial (SGLT2 inhibitors combined with metformin, Placebo combined with metformin)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • SGLT2 inhibitors combined with metformin
  • Placebo combined with metformin
  • (no location specified)
Jul 21, 2023

Itch Trial in Aalborg (Zyclara 3.75 % Topical Cream, Prudoxin, Histamine)

Withdrawn
  • Itch
  • Zyclara 3.75 % Topical Cream
  • +5 more
  • Aalborg, Nordjylland, Denmark
    Aalborg University
Jan 13, 2021

Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer Trial in New York (Radiation, Imiquimod, Cyclophosphamide)

Completed
Has Results
  • Breast Cancer
  • +2 more
  • Radiation
  • +2 more
  • New York, New York
    New York University Medical Center
Oct 25, 2021

Solid Tumor Trial in Buffalo (entolimod, pharmacological study, laboratory biomarker analysis)

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)

Active, not recruiting
  • Prostatic Neoplasms
  • San Francisco, California
    University of California San Francisco
Sep 20, 2022

Advanced Solid Tumors, Lymphoma Trial in Sacramento (epacadostat, SD-101, Radiotherapy)

Completed
Has Results
  • Advanced Solid Tumors
  • Lymphoma
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jan 25, 2022

The Effect of Human Prostate Tissue on Platelet Activation

Completed
  • Prostate Hyperplasia
  • +2 more
    • (no location specified)
    Sep 19, 2021

    Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

    Not yet recruiting
    • Advanced/Metastatic Solid Tumors
    • Frankston, Victoria, Australia
    • +2 more
    Nov 3, 2022

    Metastatic Pancreatic Adenocarcinoma, Refractory Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in

    Active, not recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • +2 more
    • Nivolumab
    • +2 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Dec 16, 2021

    Cancer, Tumors Trial in Berlin (GSK1795091, Placebo)

    Completed
    Has Results
    • Cancer
    • Neoplasms
    • Berlin, Germany
      GSK Investigational Site
    Nov 13, 2020

    Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • +10 more
    • Atlanta, Georgia
    • +6 more
    Mar 1, 2022

    Ovarian Cancer Trial in Switzerland, United States (Durvalumab, Pegylated Liposomal Doxorubicin, Motolimod)

    Completed
    Has Results
    • Ovarian Cancer
    • Phoenix, Arizona
    • +4 more
    Aug 9, 2021

    HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)

    Not yet recruiting
    • HIV-1-infection
    • ChAdOx1.tHIVconsv1
    • +7 more
    • San Diego, California
    • +11 more
    Oct 4, 2023

    COVID19 Trial in Cairo (Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment, Isotretinoin(Aerosolized 13 cis

    Not yet recruiting
    • COVID19
    • Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment
    • +4 more
    • Cairo, Kafr El-sheikh, Egypt
    • +1 more
    Jul 29, 2021

    Tumors or Premalignant Lesions Trial in Leiden (Hespecta)

    Completed
    • Tumors or Premalignant Lesions
    • Hespecta
    • Leiden, Netherlands
      Leiden University Medical Center
    Feb 17, 2021

    Mental Disorder, Metabolic Disturbance, Feasibility Trial (liraglutide 3 mg (Saxenda®) once-daily)

    Not yet recruiting
    • Mental Disorder
    • +4 more
    • liraglutide 3 mg (Saxenda®) once-daily
    • (no location specified)
    Jun 4, 2021